An Unbiased View of China medical anti-corruption
This short article draws on McKinsey’s knowledge serving to clients navigate the international medtech landscape, as well as conversations with organization executives as well as a survey of around 23 typical supervisors (GMs) major medtech firms in China.1Survey carried out in the early Restoration stage in mid-March.Dr. Leyi Zhang is a skilled